, Volume 61, Issue 1, pp 17–18 | Cite as

Diffusion tensor imaging of the optic disc in idiopathic intracranial hypertension?

  • Halil OnderEmail author
Letter to the Editor

Dear Editor-in-Chief,

I read with great interest the article by Razek et al. in which they illustrate the results of their study investigating the utility of diffusion tensor imaging (DTI) of the optic disc in differentiating between patients with idiopathic intracranial hypertension (IIH) and control individuals [1]. The authors reported devastating results supporting the possible value of DTI parameters of the optic disc in the clinical evaluation of IIH including significant differences between patients (IIH) and controls; patients with early papilledema and advanced papilledema; patients with early visual field defects; and patients with advanced visual field defects for both parameters of DTI (FA and MD). In their study conclusion, the authors emphasized that DTI parameters of the optic disc are non-invasive reliable imaging tools that may help in the diagnosis of IIH, and they remarked that it was well correlated with the degree of papilledema and visual field defects. First, I...


Compliance with ethical standards


No funding was received for this study.

Conflict of interest

The author declares that he has no conflict of interest.

Ethical approval


Informed consent



  1. 1.
    Razek A, Batouty N, Fathy W, Bassiouny R (2018) Diffusion tensor imaging of the optic disc in idiopathic intracranial hypertension. Neuroradiology 60:1159–1166CrossRefGoogle Scholar
  2. 2.
    Wall M (2014) The importance of visual field testing in idiopathic intracranial hypertension. Continuum (Minneap Minn) 20(4 Neuro-ophthalmology):1067–1074Google Scholar
  3. 3.
    Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87(9):982–992CrossRefGoogle Scholar
  4. 4.
    Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159–1165CrossRefGoogle Scholar
  5. 5.
    Moss HE (2016) Objective measures of visual function in papilledema. Adv Ophthalmol Optom 1(1):231–247CrossRefGoogle Scholar
  6. 6.
    Group OCTS-SCfNIIHS, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K et al (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci 55(12):8173–8179CrossRefGoogle Scholar
  7. 7.
    Fraser C, Plant GT (2011) The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension. Curr Opin Neurol 24(1):12–17CrossRefGoogle Scholar
  8. 8.
    Bridges KJ, Raslan AM (2018) Utility of intracranial pressure monitoring for diagnosis of idiopathic intracranial hypertension in the absence of papilledema. World Neurosurg 111:e221–e227CrossRefGoogle Scholar
  9. 9.
    Suh SY, Kim SJ (2013) IIH with normal CSF pressures? Indian J Ophthalmol 61(11):681–682Google Scholar
  10. 10.
    Green JP, Newman NJ, Stowe ZN, Nemeroff CB (1996) “Normal pressure” pseudotumor cerebri. J Neuroophthalmol 16(4):241–246CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neurology ClinicYozgat City HospitalYozgatTurkey

Personalised recommendations